title: Letter by Behrouz et Al regarding article, "Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion".
authors.affiliation: Division of Cerebrovascular Diseases, Department of Neurology, Ohio State University College of Medicine, Columbus.
authors.forename: Réza
authors.initials: R
authors.lastname: Behrouz
authors.affiliation: Department of Neurology, Ohio State University College of Medicine, Columbus.
authors.forename: Sunil A
authors.initials: SA
authors.lastname: Mutgi
authors.affiliation: Department of Neurology, Rhode Island Hospital/Alpert Medical School of Brown University, Providence.
authors.forename: Brian
authors.initials: B
authors.lastname: Silver
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D008297:Male; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator